相关实验视频

Updated: Sep 13, 2025

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

重新利用拉福克桑胺:从寄生虫杀手到癌症战士

Teresa Pacifico¹, Lorenzo Tomassini¹, Livia Biancone^1,2

¹Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

|July 29, 2025

概括

拉福克萨尼德是一种杀虫剂,通过诱导细胞死亡和抑制癌症生长途径,显示出显著的抗癌作用. 临床前研究显示,瘤显著减少,为瘤学提供了新的治疗途径.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
药物发现药物发现药物发现

背景情况:

拉福克萨尼德是一种兽用杀虫剂.
它在各种癌症中表现出抗瘤作用.
它针对多种癌症生长和生存途径.

研究的目的:

审查rafoxanide在瘤学中的治疗潜力.
讨论它的抗癌机制和临床前疗效.
探索其在癌症治疗中的应用.

主要方法:

关于rafoxanide抗癌活性的临床前研究的综述.
对其作用机制的分析,包括ER压力,亡和途径抑制.
在小鼠癌症模型中评估疗效.

主要成果:

在临床前模型中,rafoxanide表现出显著的瘤体积减少 (高达50%) 和高无瘤率 (>80%).
有效剂量在7.5至40毫克/千克之间.
这种药物抑制了关键的瘤信号通路 (STAT3,NF-κB,c-FLIP,survivin).

结论:

拉福克萨尼德具有多目标作用模式,有利于癌症治疗.
它的新机制可能会克服对传统治疗的耐药性.
拉福克萨尼德作为一种新型抗癌治疗剂显示出前景.

关键词:

在 NF-κBB 中.在STAT3中,我们可以使用STAT3.抗虫药物是一种抗虫药物.结肠直肠癌是什么意思药物重新定位药物重新定位药物重用是为了改变药物的用途.细胞内膜网膜的压力应激化氨基化物化.免疫性细胞死亡免疫性细胞死亡尼古洛萨米德的使用方法

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Automated Preparation of [⁶⁸Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...